Addictive Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Imaging dopamine's role in drug abuse and addiction

N.D. Volkow, J.S. Fowler, G.J. Wang, R. Baler and F. Telang

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 3-8 

3! - Neurobiological substrates for the dark side of compulsivity in addiction

George F. Koob

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 18-31 

3 - A somatic marker theory of addiction

Antonio Verdejo-García and Antoine Bechara

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 48-62 

3 - Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?

Philip G. Haydon, Julie Blendy, Stephen J. Moss and F. Rob Jackson

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 83-90 

3 - Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system

Antonello Bonci and Stephanie Borgland

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 107-111 

3! - Role of lateral hypothalamic orexin neurons in reward processing and addiction

Gary Aston-Jones, Rachel J. Smith, David E. Moorman and Kimberlei A. Richardson

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 112-121 

3 - Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis

William A. Carlezon Jr. and Mark J. Thomas

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 122-132 

3 - Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

Annette E. Fleckenstein, Trent J. Volz and Glen R. Hanson

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 133-138 

3 - The endocannabinoid system as a target for the treatment of cannabis dependence

Jason R. Clapper, Regina A. Mangieri and Daniele Piomelli

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 235-243 

3! - A psychobiological framework of the substrates that mediate nicotine use during adolescence

Laura E. O'Dell

Neuropharmacology. Volume 56, Supplement 1, 2009, Pages 263-278 

3 - Increased Impulsivity during Withdrawal from Cocaine Self-Administration: Role for FosB in the Orbitofrontal Cortex

Catharine A. Winstanley, Ryan K. Bachtell, David E.H. Theobald,Samuel Laali, Thomas A. Green, Arvind Kumar, Sumana Chakravarty,David W. Self and Eric J. Nestler

Cerebral Cortex 2009 19(2):435-444 

 

GRATIS 3! - Variation in dopamine genes influences responsivity of the human reward system

Jean-Claude Dreher, Philip Kohn, Bhaskar Kolachana, Daniel R. Weinberger and Karen Faith Berman

PNAS January 13, 2009 vol. 106 no. 2 617-622

 

3 - Prevalence, timing, and predictors of transitions from inhalant use to Inhalant Use Disorders

Brian E. Perron, Matthew O. Howard, Samopriyo Maitra and Michael G. Vaughn

Drug and Alcohol Dependence. Volume 100, Issue 3, 1 March 2009, Pages 277-284

 

3 - Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving

Thomas Hillemacher, Helge Frieling, Thomas Hartl, Julia Wilhelm, Johannes Kornhuber and Stefan Bleich

Journal of Psychiatric Research. Volume 43, Issue 4, January 2009, Pages 388-392

 

3 - Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics

Neal L. Benowitz

Annual Review of Pharmacology and Toxicology. 2009; Vol. 49: 57-71

 

3! - A Randomized, Open-label Trial Comparing Methadone and Levo-Alpha-Acetylmethadol (LAAM) in Maintenance Treatment of Opioid Addiction

J. Wolstein, M. Gastpar, T. Finkbeiner, C. Heinrich,R. Heitkamp, T. Poehlke, N. Scherbaum

Pharmacopsychiatry 2009; 42: 1-8

5 - A Meta-Analysis of Retention in Methadone Maintenance by Dose and Dosing Strategy

Yan-ping Bao;  Zhi-min Liu;  David H. Epstein;  Cun Du;  Jie Shi; Lin Lu

The American Journal of Drug and Alcohol Abuse, Volume 35, Issue 1 January 2009 , pages 28 - 33

 

3 - Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study

AR Winstock, T. Lea, J. Copeland

Journal of Psychopharmacology, Vol. 23, No. 1, 84-93 (2009)

 

3 - Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: Recent preclinical and clinical insights

Neil E. Paterson

European Journal of Pharmacology. Volume 603, Issues 1-3, 28 January 2009, Pages 1-11

 

3! - Transfer of Buprenorphine Into Breast Milk and Calculation of Infant Drug Dose

Synnove Lindemalm, Per Nydert, Jan-Olov Svensson, Lars Stahle, and Ihsan Sarman

Journal of Human Lactation. First published on January 8, 2009

5 - A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence

James Shearer, Shane Darke, Craig Rodgers, Tim Slade, Ingrid van Beek, John Lewis, Donna Brady, Rebecca McKetin, Richard P. Mattick & AlexWodak

Addiction. Volume 104 Issue 2, Pages 224 - 233

 

3 - The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles

S Hood, G O'Neil, and G Hulse

Journal of Psychopharmacology 2009, First published on January 22

 

3 - Benzhexol-dependence resulting from self-medication for intermittent explosive disorder

Ali Abdurrahman Younis; Hamdy Fouad Moselhy

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 1 March 2009, pages 1 - 5

 

GRATIS 3! - The Smoking Cessation Aids Varenicline (Marketed as Chantix) and Bupropion (Marketed as Zyban and Generics): Suicidal Ideation and Behavior

CDER

FDA Drug Safety Newsletter. Volume 2, Number 1, 2009

 

3! - Genetic Association of the CHRNA6 and CHRNB3 Genes with Tobacco Dependence in a Nationally Representative Sample

Nicole R Hoft, Robin P Corley, Matthew B McQueen, Isabel R Schlaepfer, David Huizinga and Marissa A Ehringer

Neuropsychopharmacology (2009) 34, 698–706

 

3! - DAT Genotype Modulates Brain and Behavioral Responses Elicited by Cigarette Cues

Teresa R Franklin, Falk W Lohoff, Ze Wang, Nathan Sciortino, Derek Harper, Yin Li, Will Jens, Jeffrey Cruz, Kyle Kampman, Ron Ehrman, Wade Berrettini, John A Detre, Charles P O'Brien and Anna Rose Childress

Neuropsychopharmacology (2009) 34, 717–728

 

3! - Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

Matthijs G Bossong, Bart NM van Berckel, Ronald Boellaard, Lineke Zuurman, Robert C Schuit, Albert D Windhorst, Joop M A van Gerven, Nick F Ramsey, Adriaan A Lammertsma and René S Kahn

Neuropsychopharmacology (2009) 34, 759–766

 

GRATIS 3! - Cigarette Smoking, Nicotine Dependence, and Motivation for Smoking Cessation in Psychiatric Inpatients

Heidi Solty, David Crockford, William DWhite, Shawn Currie

Can J Psychiatry. 2009;54(1):36–45

 

3 - Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?
Marta Miquel, Rebeca Toledo, Luis I. García, Genaro A. Coria-Avila and Jorge Manzo

Current Drug Abuse Reviews. Volume 2, Number 1, January 2009

 

3 - The Role of Glial Cells in Drug Abuse
Jose Javier Miguel-Hidalgo

Current Drug Abuse Reviews. Volume 2, Number 1, January 2009

 

3 - Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction 
M. Foster Olive

Current Drug Abuse Reviews. Volume 2, Number 1, January 2009

.

Regresar a RESÚMENES ENERO 2009